OtherClinical Investigations
Detection of Neuroendocrine Tumors: 99mTc-P829 Scintigraphy Compared with 111In-Pentetreotide Scintigraphy
Rachida Lebtahi, Joseph Le Cloirec, Claire Houzard, Doumit Daou, Iradj Sobhani, Geneviève Sassolas, Michel Mignon, Patrick Bourguet and Dominique Le Guludec
Journal of Nuclear Medicine July 2002, 43 (7) 889-895;
Rachida Lebtahi
Joseph Le Cloirec
Claire Houzard
Doumit Daou
Iradj Sobhani
Geneviève Sassolas
Michel Mignon
Patrick Bourguet
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
Detection of Neuroendocrine Tumors: 99mTc-P829 Scintigraphy Compared with 111In-Pentetreotide Scintigraphy
Rachida Lebtahi, Joseph Le Cloirec, Claire Houzard, Doumit Daou, Iradj Sobhani, Geneviève Sassolas, Michel Mignon, Patrick Bourguet, Dominique Le Guludec
Journal of Nuclear Medicine Jul 2002, 43 (7) 889-895;
Detection of Neuroendocrine Tumors: 99mTc-P829 Scintigraphy Compared with 111In-Pentetreotide Scintigraphy
Rachida Lebtahi, Joseph Le Cloirec, Claire Houzard, Doumit Daou, Iradj Sobhani, Geneviève Sassolas, Michel Mignon, Patrick Bourguet, Dominique Le Guludec
Journal of Nuclear Medicine Jul 2002, 43 (7) 889-895;
Related Articles
- No related articles found.
Cited By...
- Radiopeptide Imaging and Therapy in Europe
- Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours
- Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
- Clinical and imaging follow-up after exhaustive liver resection of endocrine metastases: a 15-year monocentric experience
- Evaluation of [99mTc/EDDA/HYNIC0]Octreotide Derivatives Compared with [111In-DOTA0,Tyr3, Thr8]Octreotide and [111In-DTPA0]Octreotide: Does Tumor or Pancreas Uptake Correlate with the Rate of Internalization?
- Preclinical Evaluation of New and Highly Potent Analogues of Octreotide for Predictive Imaging and Targeted Radiotherapy
- Receptor Imaging in Oncology by Means of Nuclear Medicine: Current Status
- An Intrapatient Comparison of 99mTc-EDDA/HYNIC-TOC with 111In-DTPA-Octreotide for Diagnosis of Somatostatin Receptor-Expressing Tumors